Novartis Fights Alexion's Soliris Patent
Alexion Pharmaceuticals Inc. revealed Thursday that Swiss drug giant Novartis AG had launched a challenge to Alexion's European patent for blood disorder treatment Soliris....To view the full article, register now.
Already a subscriber? Click here to view full article